Our results on the association between GSTP1 polymorphisms and severity of clinical manifestations of COVID-19 in previously vaccinated patients may contribute to further understanding of risk factors of developing a severe form of the disease and may be useful in better selection of COVID-19 patients who need specific pharmacological strategies focusing also on oxidative stress. The gene discussed is GSTP1; the disease is COVID-19.